MedPath

Dermacyd PH_DETINBACK Tangerine Mix (Lactic Acid)- Compatibility

Phase 3
Completed
Conditions
Hygiene
Interventions
Registration Number
NCT00784160
Lead Sponsor
Sanofi
Brief Summary

The purpose of this study is to demonstrate the absence of irritation potential (primary dermic irritability and cumulated dermic irritability) and allergy (sensibilization) of the product Dermacyd PHDETINBACK Tangerine Mix (Lactic Acid).

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
53
Inclusion Criteria

Not provided

Exclusion Criteria

Not provided

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
1Lactic Acid (Dermacyd PH_DETINBACK Tangerine Mix)Lactic Acid
Primary Outcome Measures
NameTimeMethod
The absence of primary and accumulated dermical irritability and dermical sensitivity will be evaluated using International Contact Dermatitis Research Group (ICDRG) scale.Throughout the study
Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Sanofi-Aventis Administrative Office

🇧🇷

Sao Paulo, Brazil

© Copyright 2025. All Rights Reserved by MedPath